Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Eurostars - Heartpace 114245 Background Electronic pacemakers have several important shortcomings which are difficult to overcome due to their hardware-based design. Gene therapy-based biological pacemakers may provide a different platform which can overcome these limitations. Such biological pacemaker strategies center around overexpression of the pacemaker ion channel HCN2, either alone or with other transgenes to potentiate pacemaker performance, such as the skeletal muscle sodium channel SkM1. In order to develop clinically applicable pacemaker gene therapies further engineering is needed, which would benefit from a reliable small animal model. At present it is unknown if the rat AV block model can be used to evaluate ion channel-based biological pacing. Aim In the present study, we aim to validate a modified rat AV-block model for the evaluation of HCN2 and SKM1-based biological pacing. Methods AV-block was generated in female rats by epicardially applied needle ablation of the AV-nodal region, as previously described (N.K. ). Complete AV-block was confirmed 7 days post-ablation by loss of P-wave and QRS-complex association on the body surface ECG. Seven days post-ablation, 3 groups of animals were injected into the left ventricular apex with Ad5-TNNT2-HCN2, Ad5-TNNT2-SkM1 or saline (control). 14 days post-ablation, ECG analysis was performed during anesthesia under baseline and after i.v. administration of isoprenaline. Upon completion of functional testing, tissue samples were harvested followed by gene expression analysis using qPCR. Results Injection of Ad5-TNNT2-HCN2, Ad5-TNNT2-SkM1 or saline did not result in ectopic activation patterns in baseline conditions 7 days after injection. Administration of isoprenaline results in reversal of the QRS complexes 90% of total measurement time in Ad5-TNNT2-HCN2 injected animals. Saline and Ad5-TNNT2-SkM1 showed no change in activation pattern upon isoprenaline administration. Gene expression analysis revealed expression of HCN2 in the injection site following Ad5-TNNT2-HCN2 injection, with minimal spread to non-target regions. However, this analysis also showed Ad5-TNNT2-SkM1 did not express well in this context. Conclusion Our modified rat AV-block model, when administered with isoprenaline, recapitulated expected biological pacemaker activity of HCN2 gene delivery. However, lack of effective expression of SkM1 renders direct comparison of these relevant transgenes difficult. Nevertheless, we expect this rat AV-block model can provide a valuable tool for the evaluation of novel ion channel-based biological pacemaker strategies.

[Transfecting Rat Heart with Human Pacemaker Gene in Vivo to Create a Biological Pacemaker].

Adenoviral Gene Transfer of HCN4 Creates a Genetic Pacemaker in Pigs with Complete Atrioventricular Block

Overexpression of the Medium‑conductance Calcium‑activated Potassium Channel (SK4) and the HCN2 Channel to Generate a Biological Pacemaker

Abstract 4626: Optimal Dose of Adv-hHCN4 Creates Stable and Long-lasting Biopacing Activity in Cultured Ventricular Cardiomyocytes

Experimental Study of Cardiac Biological Pacemakers Constructed by Human Hyperpolarization-Activated Cyclic Nucleotide-Gated Cation 4 Channel Gene Recombinant Adenovirus

HCN2-based biological pacing in a modified rat AV-block model

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Transient pacing in pigs with complete heart block via myocardial injection of mRNA coding for the T-box transcription factor 18

Biological pacemaker created by fetal cardiomyocyte transplantation

Genetically engineered mesenchymal stem cells to create cardiac pacemaker cells

Electrophysiological effects of hyperpolarization activated cyclic nucleotide gated channel 4 overexpression in neonatal cardiomyocytes mediated by recombinant adenovirus]

Transplanted Neonatal Cardiomyocytes As A Potential Biological Pacemaker in Pigs with Complete Atrioventricular Block

Toward Biological Pacing by Cellular Delivery of Hcn2/SkM1

Genetically-engineered mesenchymal stem cells transfected with human HCN1 gene to create cardiac pacemaker cells.

[Construction of Recombinant Adenovirus Vector of Calcitonin Gene-Related Peptide Gene and Transfection to Neonatal Rat Cardiomyocytes].

Cardiac electronic pacemakers and biological Pacemakers

Mesenchymal Stem Cells Transfected with HCN2 Genes by LentiV Can Be Modified to Be Cardiac Pacemaker Cells.

Stem cell-derived cardiomyocytes expressing a dominant negative pacemaker HCN4 channel do not reduce the risk of graft-related arrhythmias

Recombinant plasmid pIRES2-EGFP-HCN2 improved pacing function in canine model of sick sinus syndrome]

Hyperpolarization-activated Cyclic Nucleotide-Gated Channel and Cardiac Biological Pacemaker: Part Ⅰ

The effect of combined transfection of ISL-1 and Tbx18 on reprogramming of neonatal rat ventricular cardiomyocytes